article thumbnail

STAT+: Life sciences deals on track to hit lowest point since 2017

STAT

If dealmaking remains consistent for the rest of the year, it would put this year on par with the number of deals made in 2017. For comparison, there were roughly 2,122 financing deals made last year. Continue to STAT+ to read the full story…

311
311
article thumbnail

eyeforpharma Barcelona 2017

pharmaphorum

eyeforpharma Barcelona 2017 Mike.Hammerton Tue, 08/08/2023 - 09:12 Bookmark this

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Pharmalittle: Life sciences deals on track to hit lowest point since 2017; EU regulators order Illumina to divest Grail

STAT

Good morning, everyone, and welcome to another busy day. We are scrambling, in fact, to update our to-do list, schedule online calls, and sort out deadlines. To cope, we are quaffing several cups of stimulation, of course. Our choice today is maple bourbon. Meanwhile, here is the latest selection of interesting items for you to peruse.

213
213
article thumbnail

Steep drop for UK industry clinical trials between 2017 and 2021

European Pharmaceutical Review

The number of industry clinical trials initiated in the UK, per year, fell by 41 percent from 2017 to 2021, according to the latest annual report on clinical research from the Association of the British Pharmaceutical Industry ( ABPI ). million people living with rare diseases in the UK.

article thumbnail

STAT+: NIH postdocs will get a raise next year — but not as much as they hoped

STAT

But the agency noted in a press release that it’s the largest year-over-year update for NIH-funded postdocs since 2017. The 8% pay bump is far short of the increase to $70,000 that was recommended by an NIH working group late last year.

293
293
article thumbnail

STAT+: As AI proliferates, biopharma companies seek to harness it in clinical trials

STAT

That was until 2017, when he founded a startup called Nucleai. For around 20 years, Avi Veidman spent his days in the Israeli intelligence community, analyzing satellite images. Now, he’s scouring biopsy samples for cancer cells. Nucleai’s technology is not searching out signs of danger.

328
328
article thumbnail

STAT+: Telehealth providers can drive antibiotic overuse — or choose to combat it

STAT

In 2017, after receiving reports about the telehealth site, an investigator for the California medical board logged on to Lemonaid using an alias. Ho Anh had just started working at Lemonaid Health when he was caught up in a sting.

319
319